Mark Bodmer

Chief Executive Officer at

Nucleome Therapeutics Ltd.

71 year

31 connections

Health Technology

Finance

Miscellaneous

Profile

Mark W.
Bodmer is currently Chief Executive Officer at Nucleome Therapeutics Ltd. Former positions include Chief Executive Officer at Biotica Technology Ltd., Hexagen Plc, and Lorantis Ltd. (1999–2004); Director at The Bioindustry Association (2015–2016); Principal at The Wellcome Trust Ltd., Schroder Ventures Holdings Plc, Apax, and JPMorgan Partners Europe; Vice President-New Medicines Therapeutics at UCB SA (2012–2016); Senior Vice President-Research & Development at Incyte Pharmaceuticals, Inc. (1998–1999); and Chief Scientific Officer, President-R&D at Evelo Biosciences, Inc. (2016–2024).
Education includes undergraduate and doctorate degrees from the University of Cambridge.

Mark Bodmer active positions

Companies	Position	Start
Nucleome Therapeutics Ltd. Nucleome Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecular drugs for autoimmune diseases	Chief Executive Officer	-

All active positions of Mark Bodmer

Former positions of Mark Bodmer

Companies	Position	End
EVELO BIOSCIENCES, INC.	Chief Tech/Sci/R&D Officer	31/01/2024
The Bioindustry Association The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services Operates as a association to encourage and promote bioscience sector	Director/Board Member	31/03/2016
UCB	Corporate Officer/Principal	31/03/2016
Lorantis Ltd. Lorantis Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs	President	31/12/2003
Incyte Pharmaceuticals, Inc. Incyte Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company	Chief Tech/Sci/R&D Officer	31/12/1998

See the detail of Mark Bodmer's experience

Training of Mark Bodmer

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark Bodmer's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	13
The Wellcome Trust Ltd. The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous Provides welfare and charitable services	Miscellaneous
Biotica Technology Ltd. Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals	Health Technology
UCB SA UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products	Health Technology
Schroder Ventures Holdings Plc Schroder Ventures Holdings Plc Financial ConglomeratesFinance Private equity firm	Finance
Incyte Pharmaceuticals, Inc. Incyte Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company	Health Technology
Hexagen Plc Hexagen Plc BiotechnologyHealth Technology Develops technology for discovery of single nucleotide polymorphisms	Health Technology
University of Cambridge University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Lorantis Ltd. Lorantis Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs	Health Technology
Apax Apax Home FurnishingsConsumer Durables Manufactures furniture	Consumer Durables
JPMorgan Partners Europe JPMorgan Partners Europe Financial ConglomeratesFinance Private equity group	Finance
The Bioindustry Association The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services Operates as a association to encourage and promote bioscience sector	Commercial Services
Evelo Biosciences, Inc. Evelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for small intestine related diseases	Health Technology
Nucleome Therapeutics Ltd. Nucleome Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecular drugs for autoimmune diseases	Health Technology